Atovaquone/Proguanil Hydrochloride

阿托伐醌/盐酸氯胍

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAtovaquone/Proguanil Hydrochloride
Drug Alias NameAtovaquone/Proguanil阿托伐醌和盐酸氯胍Atovaquone and Proguanil Hydrochloride阿托伐醌盐酸氯胍Atovaquone•Proguanil Hydrochloride +[9] 
ClassificationSmall molecules
Mechanisms of ActionCytochrome b inhibitorsDihydrofolate reductase inhibitors
TargetsDihydrofolate reductaseCytochrome b
Therapy Area/IndicationsMalaria, VivaxMalaria, FalciparumMalaria
Global Approved IndicationsMalaria, VivaxMalaria, FalciparumMalaria
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1996/10/21
Country/TerritoryUnited StatesUnited KingdomJapan
CombinationsYes AtovaquoneProguanil Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsMalaria, VivaxMalaria, FalciparumMalaria
Inactive IndicationsN/A

Other Information

ATC CodeP01BB51
Related LinksWikipediaKEGG